With or without Milost Global, financing will happenI emailed James to see if had attended this year's JP Morgan Healthcare Conference and what was the hot subject. Whether Milost comes to bat for us or not, there is plenty of financing interest.
Good morning XXXX,
Yes, we had a team at JPM. General opinion is it should be a good year for Biotech, liquid biopsy tests are very prominent at the moment, there is good money around and so financing should be possible and good.
Best,
James R Howard-Tripp, Chairman and CEO, GeneNews Ltd.